Monographie - Ipratropium bromide - Stabilis 4.0

Senaste uppdateringen :
19/11/2024

Antimuskarint medel

Ipratropium bromide

Aerosol

Stabilitet av läkemedel

Stabilitet i blandningar

Faktorer som påverkar stabiliteten

Kompatibilitet

Hänvisningar

pdf

Molekylstruktur

Aerosol

Hänvisningar

Aerosol

Hänvisningar : Ipratropium bromide

	Typ	Publikation
665	tidningen	Blondino, FE, Baker M. Stability of Nebulizer Admixtures. Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550	tidningen	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2635	tidningen	Yamreudeewoh W, Teixeira G, Mayer GE. Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution. Hosp Pharm 2008 ; 43, 4: 303-306.
2685	tidningen	Jacobson GA, Peterson GM. Stability of ipratropium bromide and salbutamol nebuliser admixtures. Int J Pharm Pract 1995 ; 3: 169-173.
2770	tidningen	Krämer I, Schwabe A, Lichtinghagen R, Kamin W. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. Pharmazie 2007 ; 62, 10: 760-766.
2774	tidningen	McKenzie J.E, Mario Cruz-Rivera M. Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. Ann Pharmacotherapy 2004 ; 38: 967-972.
2787	tidningen	Lee TY, Chen CM, Lee CN, Chaing YC. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2790	tidningen	Kamin W, Schwabe A, Krämer I. Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Int J COPD 2007 ; 1, 4: 599-607.
2803	tidningen	Bonasia PJ, McVicar WK, Williams B, Ong S. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Respiratory Care 2008 ; 683, 12: 1716-1722.
3019	tidningen	Bonasia P, Cook C, Cheng Y et al. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Curr Med Res Opin 2007 ; 23: 2477-2483.
3472	tidningen	Krämer I, Schwabe A, Kamin W. Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten. Krankenhauspharmazie 2007 ; 28, 5: 170-178.
3498	tidningen	Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

Mentions Légales